Page last updated: 2024-08-24

triazoles and sphingosine 1-phosphate

triazoles has been researched along with sphingosine 1-phosphate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujii, Y; Goitsuka, R; Harima, N; Hidano, S; Hirayama, T; Igarashi, Y; Inoue, T; Matsumoto, K; Nakazawa, K; Ohtake, H; Ono, N; Sakurai, T; Takayama, T; Tsukahara, N1
Fujii, Y; Fukasawa, Y; Goitsuka, R; Hara, T; Hirayama, T; Igarashi, Y; Ohtake, H; Ono, N; Sakurai, T; Shiozawa, F; Takahashi, S; Takayama, T; Tsukahara, N1
Fujii, Y; Goitsuka, R; Igarashi, Y; Nakazawa, K; Ohtake, H; Ono, N; Takayama, T; Ueda, Y1
Abegg, D; Adibekian, A; Childs-Disney, JL; Costales, MG; Disney, MD; Hoch, DG; Velagapudi, SP1

Other Studies

4 other study(ies) available for triazoles and sphingosine 1-phosphate

ArticleYear
Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities.
    Journal of immunology (Baltimore, Md. : 1950), 2012, Jan-01, Volume: 188, Issue:1

    Topics: Animals; Arthritis, Experimental; B-Lymphocytes; Cricetinae; Cricetulus; HEK293 Cells; Humans; Immune Tolerance; Immunosuppressive Agents; Lymphopenia; Lysophospholipids; Male; Mice; Sphingosine; Sulfones; T-Lymphocytes; Thymus Gland; Triazoles

2012
Lymphopenia induced by a novel selective S1P(1) antagonist structurally unrelated to S1P.
    Biochimica et biophysica acta, 2012, Volume: 1821, Issue:4

    Topics: Animals; Chemotaxis; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dermatitis, Contact; Ear; Edema; Female; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Hyperplasia; Leukocytes; Lymphopenia; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Protein Binding; Rats; Rats, Inbred Lew; Receptors, Lysosphingolipid; Sphingosine; Sulfonamides; Triazoles

2012
Blocking S1P interaction with S1P₁ receptor by a novel competitive S1P₁-selective antagonist inhibits angiogenesis.
    Biochemical and biophysical research communications, 2012, Mar-23, Volume: 419, Issue:4

    Topics: Cell Line, Tumor; Human Umbilical Vein Endothelial Cells; Humans; Lysophospholipids; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Sulfones; Triazoles; Vascular Endothelial Growth Factor A

2012
A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.
    Journal of the American Chemical Society, 2019, 02-20, Volume: 141, Issue:7

    Topics: Ado-Trastuzumab Emtansine; Antineoplastic Agents; Base Sequence; Benzimidazoles; Cell Line, Tumor; Drug Design; Humans; Lysophospholipids; MicroRNAs; Phosphotransferases (Alcohol Group Acceptor); Proteome; Receptor, ErbB-2; RNA Precursors; Sphingosine; Trastuzumab; Triazoles

2019